Alobresib

Alobresib Uses, Dosage, Side Effects, Food Interaction and all others data.

Alobresib is under investigation in clinical trial NCT02607228 (Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer).

Trade Name Alobresib
Generic Alobresib
Alobresib Other Names Alobresib
Type
Formula C26H23N5O2
Weight Average: 437.503
Monoisotopic: 437.185175001
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Alobresib
Alobresib

Innovators Monograph

You find simplified version here Alobresib

*** Taking medicines without doctor's advice can cause long-term problems.
Share